Advertisement
Australia markets open in 7 hours 28 minutes
  • ALL ORDS

    8,065.50
    +113.20 (+1.42%)
     
  • AUD/USD

    0.6608
    -0.0018 (-0.27%)
     
  • ASX 200

    7,793.30
    +110.90 (+1.44%)
     
  • OIL

    78.69
    +0.21 (+0.27%)
     
  • GOLD

    2,321.80
    -9.40 (-0.40%)
     
  • Bitcoin AUD

    96,351.34
    +128.10 (+0.13%)
     
  • CMC Crypto 200

    1,321.38
    -43.74 (-3.20%)
     

What You Must Know About General Moly Inc’s (NYSEMKT:GMO) Major Investors

In this article, I’m going to take a look at General Moly Inc’s (AMEX:GMO) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors. Ownership structure of a company has been found to affect share performance over time. Differences in ownership structure of companies can have a profound effect on how management’s incentives are aligned with shareholder returns, which is why we’ll take a moment to analyse GMO’s shareholder registry.

Check out our latest analysis for General Moly

AMEX:GMO Ownership_summary Jun 6th 18
AMEX:GMO Ownership_summary Jun 6th 18

Institutional Ownership

Institutional investors typically buy and sell shares in large magnitudes which can significantly sway the share price, especially when there are relatively small amounts of shares available on the market to trade. With an institutional ownership of 5.54%, GMO doesn’t seem too exposed to higher volatility resulting from institutional trading.

Insider Ownership

Another important group of shareholders are company insiders. Insider ownership has to do more with how the company is managed and less to do with the direct impact of the magnitude of shares trading on the market. GMO insiders are also influential stakeholders with 5.10% ownership in the company. An insider stake of this level indicates that executives are highly aligned with the shareholders as both stand to gain when the value of the company rises. However, it would be interesting to take a look at their buying and selling activities lately. Buying may be sign of upbeat future expectations, but selling doesn’t necessarily mean the opposite as the insiders may be motivated by financial needs or they are simply diversifying their risk.

AMEX:GMO Insider_trading Jun 6th 18
AMEX:GMO Insider_trading Jun 6th 18

General Public Ownership

The general public holds a substantial 51.80% stake in GMO, making it a highly popular stock among retail investors. This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses. This level of ownership gives retail investors the power to sway key policy decisions such as board composition, executive compensation, and potential acquisitions. This is a positive sign for an investor who wants to be involved in key decision-making of the company.

Private Company Ownership

Another group of owners that a potential investor in GMO should consider are private companies, with a stake of 31.11%. While they invest more often due to strategic interests, an investment can also be driven by capital gains through share price appreciation. An ownership of this size indicates a strong financial backing and has the potential to influence GMO’s business strategy. Thus, investors should dig deeper into GMO’s business relations with these companies and how it can affect shareholder returns in the long-term.

Next Steps:

Institutional ownership level and composition in GMO is not high nor active enough to significantly impact its investment thesis. However, if you are building an investment case for GMO, ownership structure alone should not dictate your decision to buy or sell the stock. Rather, you should be looking at fundamental drivers such as the intrinsic valuation, which is a key driver of General Moly’s share price. I urge you to complete your research by taking a look at the following:

ADVERTISEMENT
  1. Financial Health: Is GMO’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.

  2. Past Track Record: Has GMO been consistently performing well irrespective of the ups and downs in the market? Go into more detail in the past performance analysis and take a look at the free visual representations of GMO’s historicals for more clarity.

  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.